|
|
|
|
Vol. 14, Issue 7, 2781-2792, July 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


*Centre de Recherches de Biochimie
Macromoléculaire, CNRS FRE 2593, IFR24, Montpellier, France; and
Department of Veterinary Molecular Biology,
Montana State University, Bozeman, Montana 59717
Submitted September 5, 2002;
Revised February 13, 2003;
Accepted February 25, 2003
Monitoring Editor: Richard Assoian
The function of the GTPase Rac1, a molecular switch transducing intracellular signals from growth factors, in differentiation of a specific cell type during early embryogenesis has not been investigated. To address the question, we used embryonic stem (ES) cells differentiated into cardiomyocytes, a model that faithfully recapitulates early stages of cardiogenesis. Overexpression in ES cells of a constitutively active Rac (RacV12) but not of an active mutant (RacL61D38), which does not activate the NADPH oxydase generating ROS, prevented MEF2C expression and severely compromised cardiac cell differentiation. This resulted in poor expression of ventricular myosin light chain 2 (MLC2v) and its lack of insertion into sarcomeres. Thus ES-derived cardiomyocytes featured impaired myofibrillogenesis and contractility. Overexpression of MEF2C or addition of catalase in the culture medium rescued the phenotype of racV12 cells. In contrast, RacV12 specifically expressed in ES-derived ventricular cells improved the propensity of cardioblasts to differentiate into beating cardiomyocytes. This was attributed to both a facilitation of myofibrillogenesis and a prolongation in their proliferation. The dominant negative mutant RacN17 early or lately expressed in ES-derived cells prevented myofibrillogenesis and in turn beating of cardiomyocytes. We thus suggest a stage-dependent function of the GTPase during early embryogenesis.
Corresponding author. E-mail address:
puceat{at}crbm.cnrsmop.fr.
This article has been cited by other articles:
![]() |
P. Patwari and R. T. Lee Mechanical Control of Tissue Morphogenesis Circ. Res., August 1, 2008; 103(3): 234 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Lee, Y. S. Cho, and Y.-M. Han Simvastatin Suppresses Self-Renewal of Mouse Embryonic Stem Cells by Inhibiting RhoA Geranylgeranylation Stem Cells, July 1, 2007; 25(7): 1654 - 1663. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kapur and K. Banach Inositol-1,4,5-trisphosphate-mediated spontaneous activity in mouse embryonic stem cell-derived cardiomyocytes J. Physiol., June 15, 2007; 581(3): 1113 - 1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bedard and K.-H. Krause The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology Physiol Rev, January 1, 2007; 87(1): 245 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, M. Stouffs, L. Serrander, B. Banfi, E. Bettiol, Y. Charnay, K. Steger, K.-H. Krause, and M. E. Jaconi The NADPH Oxidase NOX4 Drives Cardiac Differentiation: Role in Regulating Cardiac Transcription Factors and MAP Kinase Activation Mol. Biol. Cell, September 1, 2006; 17(9): 3978 - 3988. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Veracini, M. Franco, A. Boureux, V. Simon, S. Roche, and C. Benistant Two distinct pools of Src family tyrosine kinases regulate PDGF-induced DNA synthesis and actin dorsal ruffles J. Cell Sci., July 15, 2006; 119(14): 2921 - 2934. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Brown, D. P. Del Re, and M. A. Sussman The Rac and Rho Hall of Fame: A Decade of Hypertrophic Signaling Hits Circ. Res., March 31, 2006; 98(6): 730 - 742. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Boureux, O. Furstoss, V. Simon, and S. Roche Abl tyrosine kinase regulates a Rac/JNK and a Rac/Nox pathway for DNA synthesis and Myc expression induced by growth factors J. Cell Sci., August 15, 2005; 118(16): 3717 - 3726. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Grey, A. Mery, and M. Puceat Fine-tuning in Ca2+ homeostasis underlies progression of cardiomyopathy in myocytes derived from genetically modified embryonic stem cells Hum. Mol. Genet., May 15, 2005; 14(10): 1367 - 1377. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Chachques, C. Acar, J. Herreros, J. C. Trainini, F. Prosper, N. D'Attellis, J.-N. Fabiani, and A. F. Carpentier Cellular cardiomyoplasty: clinical application Ann. Thorac. Surg., March 1, 2004; 77(3): 1121 - 1130. [Abstract] [Full Text] [PDF] |
||||